Edward Wirth

Edward Wirth is a declared insider of Asterias Biotherapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 25 March 2016 to 1 March 2019, the count stands at 21 filings.

The open-market record consists of 6 sales worth €97k, with no purchase. Other entries cover 13 share grants and 2 option exercises.

The newest entry dates from 5 March 2019: a share grant, in Asterias Biotherapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.